Literature DB >> 30661525

"The Real Cost": Reaching At-Risk Youth in a Fragmented Media Environment.

Suzanne Santiago1, Caitlin Mahoney2, Michael P Murray3, Gem Benoza4.   

Abstract

In 2014, the U.S. Food and Drug Administration launched its first youth smoking prevention media campaign, "The Real Cost," with the goal of preventing cigarette smoking among at-risk youth aged 12-17 years in the U.S. This paper examines how the paid media strategy was developed, implemented, and refined between 2013 and 2016. Specifically, this paper discusses how research and best practices informed the media targeting strategy used to implement a multifaceted national campaign that successfully reached and influenced thousands of teens at risk for cigarette smoking. SUPPLEMENT INFORMATION: This article is part of a supplement entitled Fifth Anniversary Retrospective of "The Real Cost," the Food and Drug Administration's Historic Youth Smoking Prevention Media Campaign, which is sponsored by the U.S. Food and Drug Administration.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Mesh:

Year:  2019        PMID: 30661525     DOI: 10.1016/j.amepre.2018.07.041

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  3 in total

1.  The Vaping Teenager: Understanding the Psychographics and Interests of Adolescent Vape Users to Inform Health Communication Campaigns.

Authors:  Carolyn Ann Stalgaitis; Mayo Djakaria; Jeffrey Washington Jordan
Journal:  Tob Use Insights       Date:  2020-07-30

2.  Language Gap in Reach of "The Real Cost": Examination of a Federal Mass Media Campaign From 2017 to 2019.

Authors:  Dale S Mantey; Stephanie L Clendennen; Felisa A Ruiz; Cheryl L Perry
Journal:  Nicotine Tob Res       Date:  2021-08-18       Impact factor: 4.244

3.  Effects of a National Campaign on Youth Beliefs and Perceptions About Electronic Cigarettes and Smoking.

Authors:  Anna J MacMonegle; Alexandria A Smith; Jennifer Duke; Morgane Bennett; Leah R Siegel-Reamer; Lindsay Pitzer; Jessica L Speer; Xiaoquan Zhao
Journal:  Prev Chronic Dis       Date:  2022-04-07       Impact factor: 2.830

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.